November 7, 2014

November 7, 2014

Episodes

Specialty:

All

Year:

All

EP. 1: Latest News & Insight: November 7, 2014

November 8th 2014

EP. 2: Selecting First-line Treatment in mCRC

November 8th 2014

EP. 3: Goals of Therapy in Metastatic CRC

November 8th 2014

EP. 4: Second- and Third-Line Therapies in mCRC

November 8th 2014

EP. 5: Side Effect Management With Regorafenib in mCRC

November 8th 2014

Trending on OncLive

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

Mo-Rez Advances Into Combination Studies Following Robust Responses in Gynecologic Cancers

mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC

Harold P. Freeman, MD, Pioneer of Patient Navigation and Cancer Disparities Research, Dies at 93